Literature DB >> 30003469

Rare case of a gallbladder neuroendocrine carcinoma.

Masakuni Fujii1, Hiroaki Saito2, Junji Shiode2.   

Abstract

There are no neuroectodermal cells in the gallbladder mucosa. Therefore, gallbladder neuroendocrine carcinoma (NEC) is extremely rare and has a poor prognosis. We report a case of a Japanese man in his 60s with this disease. The patient visited a family doctor for epigastralgia. Blood tests showed no abnormalities, including tumor markers, such as CEA and CA19-9. Abdominal ultrasonography (US) showed a low-echoic mass, 39 × 30 mm, with clear boundaries to the liver from the fundus of the gallbladder. Contrast-enhanced computed tomography showed that the tumor was enhanced early and washed out. Diffusion-weighted MRI showed a high signal. We suspected liver invasion of gallbladder cancer and performed a cholecystectomy, S4 and S5 hepatectomy, and lymphadenectomy. The resected whitish tumor was 29 × 22 mm. The tumor cells had honeycomb growth to the liver from the gallbladder. Tumor cells were poorly differentiated, and there was no stricture of the gland duct. Immunostaining showed that the tumor cells were positive for CD56, chromogranin A and synaptophysin, and about 30% were positive for Ki-67. Our diagnosis was gallbladder NEC with liver invasion. Although most malignant gallbladder tumors are adenocarcinomas, this case indicates that gallbladder NEC should be considered as a differential diagnosis of gallbladder tumor.

Entities:  

Keywords:  Gallbladder tumor; Liver invasion; Neuroendocrine carcinoma; Neuroendocrine tumor

Mesh:

Year:  2018        PMID: 30003469     DOI: 10.1007/s12328-018-0883-z

Source DB:  PubMed          Journal:  Clin J Gastroenterol        ISSN: 1865-7265


  35 in total

1.  Combined adenosquamous and large-cell neuroendocrine carcinoma of the gallbladder.

Authors:  Aurelia Noske; Stefan Pahl
Journal:  Virchows Arch       Date:  2006-03-29       Impact factor: 4.064

2.  A case of mixed adenoneuroendocrine carcinoma of the gallbladder arising from an intracystic papillary neoplasm associated with pancreaticobiliary maljunction.

Authors:  Yoshiyuki Meguro; Noriyoshi Fukushima; Masaru Koizumi; Naoya Kasahara; Masanobu Hydo; Kazue Morishima; Naohiro Sata; Alan T Lefor; Yoshikazu Yasuda
Journal:  Pathol Int       Date:  2014-08-22       Impact factor: 2.534

3.  Regional lymphadenectomy is indicated in the surgical treatment of pancreatic neuroendocrine tumors (PNETs).

Authors:  Yassar M Hashim; Kathryn M Trinkaus; David C Linehan; Steven S Strasberg; Ryan C Fields; Dengfeng Cao; William G Hawkins
Journal:  Ann Surg       Date:  2014-02       Impact factor: 12.969

4.  High-grade neuroendocrine carcinomas of the gallbladder and bile duct: Report of four cases with pathological correlation.

Authors:  Su Ryoung Jun; Jeong Min Lee; Joon Koo Han; Byung Ihn Choi
Journal:  J Comput Assist Tomogr       Date:  2006 Jul-Aug       Impact factor: 1.826

5.  A large cell neuroendocrine carcinoma of the gall bladder: diagnosis with 18FDG-PET/CT-guided biliary cytology and treatment with combined chemotherapy achieved a long-term stable condition.

Authors:  Yusuke Okuyama; Akihumi Fukui; Yasuyuki Enoki; Hiroyuki Morishita; Norimasa Yoshida; Sotaro Fujimoto
Journal:  Jpn J Clin Oncol       Date:  2013-03-26       Impact factor: 3.019

6.  Predictive value of 18F-FDG PET and somatostatin receptor scintigraphy in patients with metastatic endocrine tumors.

Authors:  Etienne Garin; Florence Le Jeune; Anne Devillers; Marc Cuggia; Anne-Sophie de Lajarte-Thirouard; Catherine Bouriel; Eveline Boucher; Jean-Luc Raoul
Journal:  J Nucl Med       Date:  2009-05-14       Impact factor: 10.057

7.  Biphasic large cell neuroendocrine carcinoma--pure mucinous carcinoma of the gallbladder (MANEC): a unique combination.

Authors:  S Russo; F Russo; F M Maiello; B Paolini; A Carrabba; A De Gregorio
Journal:  Pathologica       Date:  2012-08

8.  Large cell neuroendocrine carcinoma of the gallbladder: long survival achieved by multimodal treatment.

Authors:  Chigusa Shimono; Kazuhiro Suwa; Morio Sato; Shintaro Shirai; Katsuyuki Yamada; Yasushi Nakamura; Masatoshi Makuuchi
Journal:  Int J Clin Oncol       Date:  2009-08-25       Impact factor: 3.402

9.  A Practical Approach to the Classification of WHO Grade 3 (G3) Well-differentiated Neuroendocrine Tumor (WD-NET) and Poorly Differentiated Neuroendocrine Carcinoma (PD-NEC) of the Pancreas.

Authors:  Laura H Tang; Olca Basturk; Jillian J Sue; David S Klimstra
Journal:  Am J Surg Pathol       Date:  2016-09       Impact factor: 6.394

10.  Two cases of neuroendocrine carcinoma of the gallbladder.

Authors:  Hao Chen; Yan-Ying Shen; Xing-Zhi Ni
Journal:  World J Gastroenterol       Date:  2014-09-07       Impact factor: 5.742

View more
  2 in total

1.  Neuroendocrine Carcinoma of the Gallbladder.

Authors:  Daniel A Vidal Panduro; Elizabeth Zegarra Buitron; Omar J Cochella Tizon; Domingo A Morales Luna
Journal:  Cureus       Date:  2022-07-19

2.  Flushing as atypical initial presentation of functional gallbladder neuroendocrine carcinoma: A case report.

Authors:  Ming Jin; Bo Zhou; Xiong-Ling Jiang; Qi-Yi Zhang; Xiang Zheng; Yuan-Cong Jiang; Sheng Yan
Journal:  World J Gastroenterol       Date:  2020-02-14       Impact factor: 5.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.